publication venue for
- [Evaluation of clinical characteristics, MYD88(L265P) mutation, CXCR4(WHIM) mutation and prognosis in Waldenstrm macroglobulinemia: A single center retrospective study of 93 patients].. 38:494-498. 2017
- [Long-term safety and efficacy of high-dose cytarabine consolidation in patients with acute myeloid leukemia].. 38:330-333. 2017
- [Analysis of the safety and efficacy of 60 mgm-2d-1daunorubicin combined with standard dose of cytarabine as induction therapy in acute myeloid leukemia patients under 65 years old].. 37:892-897. 2016
- [Efficacy and safety analysis of the combination of cladribine, cytarabine, granulocyte colonystimulating factor (CLAG) regime in patients with refractory or relapsed acute myeloid leukemia].. 37:571-575. 2016